Yıl: 2006 Cilt: 6 Sayı: 4 Sayfa Aralığı: 314 - 321 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey

Öz:
Amaç: Türk erkek ve kadınlarını temsil eden bir örneklemde, tip 2 diyabetin insidansı, bazı öngördürücüleri ile akıbetini prospektif biçimde, prevalansını da kesitsel olarak araştırmak. Yöntemler: Ortalama yaşı 48 (±12) olan 3401 kişilik bir örneklem 19,050 kişi-yılı tutan bir izlemede öne dönük olarak değerlendirildi. Diyabetes mellitüs'lü (DM) bireylerin tanısı Amerikan Diyabet Cemiyeti kriterlerine göre kondu. Fatal ve fatal olmayan koroner kalp hastalığı (KKH) klinik bulgu ve istirahat elektrokardiyografisinin Minnesota kodlarıyla belirlendi. Abdominal obezite için erkekte ≥95 cm, kadında ≥91 cm'lik sınırlar uygulandı. Öne dönük değerlendirmelerde, başlangıçtaki DM ve KKH vakaları dışlandı. Bulgular: Nüfusu ≥35 yaş olan kesim için %11.0'e karşılık gelen bir DM prevalansı (tahminen 2.89 milyon) saptandı. Ortalama 5.9 yıllık takipte 223 kişide yeni DM gelişmesi karşılığında, 1000 kişi-yılında kadında 11.0, erkekte 12.4'lük bir insidans hesaplandı; bu da ülke bazında yılda 300 bin kişilik insidans ifade eder. Geri kalanlara kıyasla, yeni gelişen diyabetli kişilerde başlangıçtaki HDL-kolesterol benzer olup şu risk değişkenleri anlamlı farklıydı: Yaş (5 yıl), bel çevresi (7 cm), kan basıncı (12/6 mmHg), apolipoprotein B (7 mg/dl), total kolesterol (14 mg/dl), açlık trigliseridleri (yalnız kadında, 52 mg/dl). Diyabetes mellitüs'ün anlamlı bağımsız öngördürücüleri olarak abdominal obezite (RR 2.61 [%95GA 1.87; 3.63]) ile yaş her iki cinsiyette, erkekte ise hipertansiyon (RR 1.81 [%95GA 1.10; 2.98]) ve düşük HDL-kolesterol ortaya çıktı. Cinsiyet, yaş, hipertansiyon, bel çevresi, total kolesterol ve sigara içimi için ayarlandıktan sonra, DM 1.81'lik (%95GA 1.19; 2.75) bir nisbi risk ile fatal ve fatal olmayan KKH'nın anlamlı bağımsız bir öngördürücüsüydü. Sonuçlar: Halkımızda halen 305 bin olan DM insidansı hızla artmakta, prevalansı da benzer şekilde yükselmektedir. Diyabetin kadınlarda esas belirleyicisi abdominal obezite iken, insülin direnci bu bağlamda daha zayıf görünmektedir. Çok değişkenli ayarlamada DM, fatal ve fatal olmayan KKH'nın anlamlı bağımsız öngördürücüsüdür. Bu gözlemler, göbeklilik “salgını”nı durdurucu veya tersine dönüştürücü önlemlere şiddetle ihtiyaç olduğunun altını çizmektedir.
Anahtar Kelime: Koroner arteriyoskleroz Kan basıncı İleriye dönük çalışma Kesitsel çalışmalar Risk faktörleri Yaş dağılımı Yaygınlık Trigliseridler Görülme sıklığı Kolesterol Cinsiyet dağılımı Diabetes mellitus, tip 2

Konular: Kalp ve Kalp Damar Sistemi

Türkiye’de tip 2 diyabetin prevalansı, insidansı, öngördürücüleri ve akıbeti

Öz:
Objectives: To investigate prospectively the incidence, certain predictors and outcomes of type 2 diabetes (DM), as well as to determine its prevalence cross-sectionally, in a representative sample of Turkish men and women. Methods: Prospective evaluation of 3401 male and female participants (aged 48.2 ±12 years). Follow-up constituted 19,050 person-years. Individuals with DM were diagnosed with criteria of the American Diabetes Association. Fatal and nonfatal coronary heart disease (CHD) was identified by clinical findings and Minnesota coding of resting electrocardiograms. Cut-points of ≥95 cm in males and ≥91 cm in females were selected for abdominal obesity. For prospective evaluations, cases with DM or CHD were excluded. Results: Prevalence of DM in Turkish adults was estimated as 2.89 million (11.0% of the population aged ≥35 years). Over a mean follow-up of 5.9 years, incident DM developed in 223 subjects, yielding an incidence per 1000 person-years of 11.0 in women and 12.4 in men. This corresponded to a 300,000 annual incidence. Following risk parameter levels but not HDL-cholesterol were significantly elevated at baseline in subjects developing DM compared to those without: age (5 years), waist girth (7 cm), blood pressure (12/6 mmHg), apolipoprotein B (7 mg/dl), total cholesterol (14 mg/dl), and fasting triglycerides (only in women, 52 mg/dl). Abdominal obesity (RR 2.61 [95%CI 1.87; 3.63]) and age in both genders, hypertension (RR 1.81 [95%CI 1.10; 2.98]) and low HDL-cholesterol in men alone were significant independent predictors of DM. Diabetes mellitus was a significant and independent predictor of fatal and nonfatal CHD, with a RR of 1.81 (95%CI 1.19; 2.75), after adjustment for sex, age, hypertension, waist circumference, serum total cholesterol and smoking status. Conclusions: The annual incidence of DM in Turkey rises very rapidly, currently stands at 300,000, and, hence, its prevalence also rises correspondingly. Insulin resistance appears to be a weak determinant of DM in Turkish women while abdominal obesity is the main determinant. Multivariately adjusted DM is a significant independent predictor of fatal and nonfatal CHD. These observations emphasize that measures to reverse or stop the “epidemic” of abdominal obesity are severely required.
Anahtar Kelime: Age Distribution Prevalence Triglycerides Incidence Cholesterol Sex Distribution Diabetes Mellitus, Type 2 Coronary Arteriosclerosis Blood Pressure Prospective Studies Cross-Sectional Studies Risk Factors

Konular: Kalp ve Kalp Damar Sistemi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Survey 1988-1994. Diabetes Care 1998; 28: 518-24.
  • 2. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50.
  • 3. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
  • 4. Satman I, Yilmaz T, Sengul A, Salman S, Salman F, Uygur S, et al. Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabetes Care 25: 1551-6.
  • 5. Onat A, Yıldırım B, Ceyhan K, Keleş İ, Başar Ö, Sansoy V, et al. Halkımızda diyabet ve glukoz intoleransı: koroner mortalite ve morbiditeye prospektif etkisi, prevalansında artma. Türk Kardiyol Dern Arş 2001; 29; 268-73.
  • 6. Onat A, Hergenç G, Keleş İ, Doğan Y, Türkmen S, Sansoy V. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome: prospective study of a cohort with normal glucose metabolism. Metabolism 2005; 54: 800-8.
  • 7. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001; 156: 1-10.
  • 8. Onat A, Avcı GŞ, Şenocak M, Örnek E, Gözükara Y. Plasma lipids and their interrelation in Turkish adults. J Epidem Commun Health 1992; 46: 470-6.
  • 9. Mather KJ, Hunt AE, Steinber HO, Paradisi G, Hook G, Katz A, et al: Repeatability characteristics of simple indices of insulin resistance: implications for research applications. J Clin Endocrinol Metab 2001; 86: 5457-64.
  • 10. Razak F, Anand S, Vuksan V, Davis B, Jacobs R, Teo KK, et al. SHARE Investigators. Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. Int J Obes 2005; 29: 656-67.
  • 11. Onat A, Avcı GŞ, Barlan MM, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes 2004; 28: 1018-25.
  • 12. Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis Epub 2006 May 7.
  • 13. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods, 2nd edition. Geneva: WHO; 1982.
  • 14. Satman İ, Yılmaz MT, Şengül AM, et al; TURDEP Çalışma Grubu. TURDEP Çalışması: Türkiye'de diyabet prevalansı ve diyabet gelişmesine etkili faktörler. In: Hatemi HH, editor. Türkiye'de Diyabet ve Metabolik Sendrom Epidemiyolojisi. Istanbul: Bayer Health Care; 2005. p 43
  • 15. US Department of Health and Human Services, Centers for Di sease Control and Prevention. National Diabetes Fact Sheet: United States, 2003. Silver Spring, Md: Centers for Disease Control; 2003. Available at: http://www.cdc.gov/diabetes/pubs/pdfs/ndfs_2003.pdf.
  • 16. Miller NE. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 1987; 113: 589-97.
  • 17. Onat A, Hergenç G, Uzunlar B, Ceyhan K, Uyarel H, Yazıcı M, et al. Türk toplumunda koroner risk faktörü olarak HDL-kolesterol: öngördürücülüğü, belirleyicileri ve ilişkileri (summary in English). Türk Kardiyol Dern Arş 2003; 31: 9-16.
  • 18. Mahley RW, Pepin J, Palaoğlu KE, Malloy MJ, Kane JP, Bersot TP. Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase: high density lipoprotein characterization and gender-specific effects of apolipoprotein E genotype. J Lipid Res 2000; 41: 1290-301.
  • 19. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987; 28: 613-28.
  • 20. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal obesity and overall obesity in predicting type 2 diabetes among men. Am J Clin Nutr 2005; 81: 555-63.
  • 21. Mykkänen L, Kuusisto J, Pyörälä K, Laakso M. Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 1993; 36: 553-9.
  • 22. D'Agostino RB Jr, Hamman RF, Karter AJ, Mykkänen L, Wagenknecht LE, Haffner SM. Insulin Resistance Atherosclerosis Study Investigators. Cardiovascular disease risk factors predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes Care 2004; 27: 2234-40.
  • 23. Wang JJ, Qiao Q, Miettinen ME, Lappalainen J, Hu G, Tuomilehto J. The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diabetes Care 2004; 27: 2429-37.
  • 24. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-34.
APA Onat A, HERGENÇ G, UYAREL H, CAN G, özhan h (2006). Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. , 314 - 321.
Chicago Onat Altan,HERGENÇ Gülay,UYAREL Hüseyin,CAN Günay,özhan hakan Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. (2006): 314 - 321.
MLA Onat Altan,HERGENÇ Gülay,UYAREL Hüseyin,CAN Günay,özhan hakan Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. , 2006, ss.314 - 321.
AMA Onat A,HERGENÇ G,UYAREL H,CAN G,özhan h Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. . 2006; 314 - 321.
Vancouver Onat A,HERGENÇ G,UYAREL H,CAN G,özhan h Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. . 2006; 314 - 321.
IEEE Onat A,HERGENÇ G,UYAREL H,CAN G,özhan h "Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey." , ss.314 - 321, 2006.
ISNAD Onat, Altan vd. "Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey". (2006), 314-321.
APA Onat A, HERGENÇ G, UYAREL H, CAN G, özhan h (2006). Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. Anadolu Kardiyoloji Dergisi, 6(4), 314 - 321.
Chicago Onat Altan,HERGENÇ Gülay,UYAREL Hüseyin,CAN Günay,özhan hakan Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. Anadolu Kardiyoloji Dergisi 6, no.4 (2006): 314 - 321.
MLA Onat Altan,HERGENÇ Gülay,UYAREL Hüseyin,CAN Günay,özhan hakan Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. Anadolu Kardiyoloji Dergisi, vol.6, no.4, 2006, ss.314 - 321.
AMA Onat A,HERGENÇ G,UYAREL H,CAN G,özhan h Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. Anadolu Kardiyoloji Dergisi. 2006; 6(4): 314 - 321.
Vancouver Onat A,HERGENÇ G,UYAREL H,CAN G,özhan h Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey. Anadolu Kardiyoloji Dergisi. 2006; 6(4): 314 - 321.
IEEE Onat A,HERGENÇ G,UYAREL H,CAN G,özhan h "Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey." Anadolu Kardiyoloji Dergisi, 6, ss.314 - 321, 2006.
ISNAD Onat, Altan vd. "Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey". Anadolu Kardiyoloji Dergisi 6/4 (2006), 314-321.